Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the US

Pediatrics. 2003 Dec;112(6 Pt 1):1422-3. doi: 10.1542/peds.112.6.1422.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Extracorporeal Membrane Oxygenation / economics*
  • Humans
  • Hypoxia / economics*
  • Hypoxia / therapy*
  • Infant, Newborn
  • Nitric Oxide / economics*
  • Nitric Oxide / therapeutic use*
  • Respiratory Insufficiency / economics*
  • Respiratory Insufficiency / therapy*
  • Vasodilator Agents / economics*
  • Vasodilator Agents / therapeutic use*

Substances

  • Vasodilator Agents
  • Nitric Oxide